Avadel Pharmaceuticals plc (AVDL)
USD 6.6
(-2.94%)
USD 6.6
(-2.94%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 10.38 Million USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 3.57 Million USD | -25.16% |
| 2018 | 4.77 Million USD | -22.53% |
| 2017 | 6.15 Million USD | 88.98% |
| 2016 | 3.25 Million USD | -21.59% |
| 2015 | 4.15 Million USD | -38.25% |
| 2014 | 6.72 Million USD | 78.87% |
| 2013 | 3.76 Million USD | 147.5% |
| 2012 | 1.52 Million USD | -9.25% |
| 2011 | 1.67 Million USD | 94.32% |
| 2010 | 862 Thousand USD | -19.59% |
| 2009 | 1.07 Million USD | -41.64% |
| 2008 | 1.83 Million USD | 3.73% |
| 2007 | 1.77 Million USD | -46.85% |
| 2006 | 3.33 Million USD | 217.33% |
| 2005 | 1.05 Million USD | -34.25% |
| 2004 | 1.59 Million USD | 51.09% |
| 2003 | 1.05 Million USD | 181.87% |
| 2002 | 375 Thousand USD | -34.09% |
| 2001 | 569 Thousand USD | -33.84% |
| 2000 | 860 Thousand USD | 362.37% |
| 1999 | 186 Thousand USD | -76.87% |
| 1998 | 804 Thousand USD | 704.0% |
| 1997 | 100 Thousand USD | -50.0% |
| 1996 | 200 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 11.92 Million USD | 14.91% |
| 2024 Q2 | 13.31 Million USD | 11.61% |
| 2023 Q4 | 10.38 Million USD | 96.37% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | 5.28 Million USD | 267.34% |
| 2023 FY | 10.38 Million USD | 0.0% |
| 2023 Q2 | 1.43 Million USD | 0.0% |
| 2022 Q4 | - USD | -100.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q1 | 5.31 Million USD | 0.0% |
| 2022 Q2 | 3.88 Million USD | -27.01% |
| 2022 Q3 | 3.74 Million USD | -3.5% |
| 2021 Q3 | 2.78 Million USD | -48.4% |
| 2021 Q4 | - USD | -100.0% |
| 2021 Q1 | 6.46 Million USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q2 | 5.4 Million USD | -16.48% |
| 2020 FY | - USD | -100.0% |
| 2020 Q1 | 3.52 Million USD | -1.32% |
| 2020 Q2 | 4.15 Million USD | 17.91% |
| 2020 Q3 | 2.9 Million USD | -30.12% |
| 2020 Q4 | - USD | -100.0% |
| 2019 Q3 | 2.26 Million USD | -13.11% |
| 2019 Q1 | 4.25 Million USD | -10.73% |
| 2019 FY | 3.57 Million USD | -25.16% |
| 2019 Q4 | 3.57 Million USD | 57.96% |
| 2019 Q2 | 2.6 Million USD | -38.91% |
| 2018 Q2 | 5.72 Million USD | -3.77% |
| 2018 Q1 | 5.94 Million USD | -3.39% |
| 2018 Q4 | 4.77 Million USD | -20.9% |
| 2018 Q3 | 6.03 Million USD | 5.35% |
| 2018 FY | 4.77 Million USD | -22.53% |
| 2017 Q2 | 5.74 Million USD | 6.31% |
| 2017 Q4 | 6.15 Million USD | 4.89% |
| 2017 FY | 6.15 Million USD | 88.98% |
| 2017 Q1 | 5.4 Million USD | 65.93% |
| 2017 Q3 | 5.87 Million USD | 2.14% |
| 2016 Q3 | 3.9 Million USD | 7.39% |
| 2016 Q4 | 3.25 Million USD | -16.65% |
| 2016 Q2 | 3.64 Million USD | -31.48% |
| 2016 FY | 3.25 Million USD | -21.59% |
| 2016 Q1 | 5.31 Million USD | 27.85% |
| 2015 FY | 4.15 Million USD | -38.25% |
| 2015 Q1 | 5.49 Million USD | -18.31% |
| 2015 Q2 | 5.75 Million USD | 4.62% |
| 2015 Q4 | 4.15 Million USD | 0.0% |
| 2014 Q3 | 6.47 Million USD | 16.34% |
| 2014 Q4 | 6.72 Million USD | 3.95% |
| 2014 Q2 | 5.56 Million USD | 8.42% |
| 2014 FY | 6.72 Million USD | 78.87% |
| 2014 Q1 | 5.13 Million USD | 36.42% |
| 2013 Q1 | 1.88 Million USD | 23.95% |
| 2013 Q2 | 1.85 Million USD | -1.59% |
| 2013 Q3 | 2.89 Million USD | 55.99% |
| 2013 Q4 | 3.76 Million USD | 30.08% |
| 2013 FY | 3.76 Million USD | 147.5% |
| 2012 Q4 | 1.52 Million USD | 0.0% |
| 2012 Q2 | 1.59 Million USD | -15.97% |
| 2012 FY | 1.52 Million USD | -9.25% |
| 2012 Q1 | 1.9 Million USD | 13.61% |
| 2011 FY | 1.67 Million USD | 94.32% |
| 2011 Q1 | 854 Thousand USD | -0.93% |
| 2011 Q2 | 906 Thousand USD | 6.09% |
| 2011 Q3 | 1.69 Million USD | 87.53% |
| 2011 Q4 | 1.67 Million USD | -1.41% |
| 2010 Q1 | 826 Thousand USD | -22.95% |
| 2010 FY | 862 Thousand USD | -19.59% |
| 2010 Q4 | 862 Thousand USD | -19.44% |
| 2010 Q3 | 1.07 Million USD | 14.81% |
| 2010 Q2 | 932 Thousand USD | 12.83% |
| 2009 Q3 | 2.15 Million USD | -16.78% |
| 2009 Q4 | 1.07 Million USD | -50.3% |
| 2009 FY | 1.07 Million USD | -41.64% |
| 2009 Q1 | 2.09 Million USD | 13.94% |
| 2009 Q2 | 2.59 Million USD | 23.84% |
| 2008 Q3 | 1.68 Million USD | -23.29% |
| 2008 FY | 1.83 Million USD | 3.73% |
| 2008 Q1 | 2.21 Million USD | 25.24% |
| 2008 Q2 | 2.19 Million USD | -1.08% |
| 2008 Q4 | 1.83 Million USD | 9.15% |
| 2007 FY | 1.77 Million USD | -46.85% |
| 2007 Q4 | 1.77 Million USD | -39.93% |
| 2007 Q3 | 2.94 Million USD | -3.79% |
| 2007 Q2 | 3.06 Million USD | -0.42% |
| 2007 Q1 | 3.07 Million USD | -7.65% |
| 2006 Q3 | 1.35 Million USD | 7.04% |
| 2006 Q4 | 3.33 Million USD | 146.09% |
| 2006 Q2 | 1.26 Million USD | 29.88% |
| 2006 Q1 | 974 Thousand USD | -7.24% |
| 2006 FY | 3.33 Million USD | 217.33% |
| 2005 Q2 | 966 Thousand USD | -14.44% |
| 2005 FY | 1.05 Million USD | -34.25% |
| 2005 Q4 | 1.05 Million USD | -10.33% |
| 2005 Q3 | 1.17 Million USD | 21.22% |
| 2005 Q1 | 1.12 Million USD | -29.3% |
| 2004 Q4 | 1.59 Million USD | 21.91% |
| 2004 Q3 | 1.31 Million USD | 0.0% |
| 2004 FY | 1.59 Million USD | 51.09% |
| 2004 Q1 | 991 Thousand USD | -6.24% |
| 2004 Q2 | 1.31 Million USD | 32.19% |
| 2003 FY | 1.05 Million USD | 181.87% |
| 2003 Q4 | 1.05 Million USD | 93.94% |
| 2003 Q2 | 1.06 Million USD | 101.32% |
| 2003 Q1 | 531 Thousand USD | 41.6% |
| 2003 Q3 | 545 Thousand USD | -49.02% |
| 2002 Q3 | 351 Thousand USD | 0.0% |
| 2002 FY | 375 Thousand USD | -34.09% |
| 2002 Q4 | 375 Thousand USD | 6.84% |
| 2001 Q4 | 569 Thousand USD | 0.0% |
| 2001 FY | 569 Thousand USD | -33.84% |
| 2000 Q4 | 860 Thousand USD | 0.0% |
| 2000 FY | 860 Thousand USD | 362.37% |
| 1999 Q4 | 186 Thousand USD | 0.0% |
| 1999 FY | 186 Thousand USD | -76.87% |
| 1998 Q4 | 804 Thousand USD | 0.0% |
| 1998 Q1 | 200 Thousand USD | 100.0% |
| 1998 FY | 804 Thousand USD | 704.0% |
| 1997 FY | 100 Thousand USD | -50.0% |
| 1997 Q4 | 100 Thousand USD | 0.0% |
| 1996 Q4 | 200 Thousand USD | 0.0% |
| 1996 FY | 200 Thousand USD | 0.0% |
| 1996 Q1 | 200 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cosmos Health Inc. | 4.78 Million USD | -116.744% |
| Safety Shot Inc | 1.86 Million USD | -455.185% |
| Bright Green Corporation | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | 93.176% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 90.665% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -53.346% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 67.896% |
| Dynavax Technologies Corporation | 53.29 Million USD | 80.522% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 84.182% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 10.878% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 90.053% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -81.002% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -81.002% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -1181.866% |
| Journey Medical Corporation | 10.2 Million USD | -1.705% |
| Alpha Teknova, Inc. | 11.59 Million USD | 10.471% |
| Procaps Group, S.A. | 96.83 Million USD | 89.281% |
| Theratechnologies Inc. | 6.06 Million USD | -71.118% |
| Harrow Health, Inc. | 10.86 Million USD | 4.481% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -281.758% |
| Biofrontera Inc. | 10.9 Million USD | 4.84% |
| DURECT Corporation | 2.21 Million USD | -367.778% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 86.591% |
| Cronos Group Inc. | 30.33 Million USD | 65.787% |
| OptiNose, Inc. | 8.05 Million USD | -28.912% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -1037999900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -82.136% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 63.261% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -287.731% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -125.194% |
| Radius Health, Inc. | 278.64 Million USD | 96.275% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -210.475% |
| ProPhase Labs, Inc. | 3.84 Million USD | -170.242% |
| Phibro Animal Health Corporation | 265.91 Million USD | 96.096% |
| Procaps Group S.A. | 96.83 Million USD | 89.281% |
| Alvotech | 74.43 Million USD | 86.055% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.701% |
| Rockwell Medical, Inc. | 5.87 Million USD | -76.801% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 17.834% |
| SIGA Technologies, Inc. | 64.21 Million USD | 83.836% |
| Tilray Brands, Inc. | 252.08 Million USD | 95.882% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 74.036% |
| Shineco, Inc. | 1.58 Million USD | -553.436% |
| PetIQ, Inc. | 159.3 Million USD | 93.484% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 6894.172% |
| Incannex Healthcare Limited | -10.01 Million USD | 203.645% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 72.898% |
| Alimera Sciences, Inc. | 1.87 Million USD | -452.422% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 72.457% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -544.564% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -131.541% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -3980.959% |
| Hempacco Co., Inc. | 2.54 Million USD | -308.239% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 86.055% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 78.282% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 83.789% |
| Currenc Group, Inc. | 732.91 Thousand USD | -1316.27% |
| Kamada Ltd. | 87.74 Million USD | 88.171% |
| Indivior PLC | 141.79 Million USD | 92.68% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -2054.242% |
| Flora Growth Corp. | 8.5 Million USD | -22.003% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -3980.959% |
| Evolus, Inc. | 10.99 Million USD | 5.619% |
| HUTCHMED (China) Limited | 50.25 Million USD | 79.347% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 90.192% |
| Akanda Corp. | 1.28 Million USD | -706.593% |